Involvement of the CD95 (APO-1/Fas) receptor and ligand in liver damage
- PMID: 7595193
- PMCID: PMC2192196
- DOI: 10.1084/jem.182.5.1223
Involvement of the CD95 (APO-1/Fas) receptor and ligand in liver damage
Abstract
Apoptosis occurs in the normal liver and in various forms of liver disease. The CD95 (APO-1/Fas) (CD95) receptor mediates apoptosis, and liver cells in animal models are acutely sensitive to apoptosis initiated by this receptor. We have used primary human hepatocytes as a model system to investigate CD95-mediated apoptotic liver damage. Treatment of fresh human hepatocytes with low concentrations of agonistic antibodies against CD95 resulted in apoptosis of > 95% of the cultured liver cells within 4 and 7.5 h. Immunohistology of a panel of explanted liver tissues revealed that hepatocytes in normal livers (n = 5) and in alcoholic cirrhosis (n = 13) expressed low constitutive levels of CD95. CD95 receptor expression was highly elevated in hepatocytes in hepatitis B virus-related cirrhosis (n = 9) and in acute liver failure (n = 8). By in situ hybridization CD95 ligand messenger RNA expression was absent in normal liver but detected at high levels in livers with ongoing liver damage. In cases of hepatitis B virus-related cirrhosis and acute hepatic failure, ligand expression was found primarily in areas with lymphocytic infiltration. In contrast, in patients with alcoholic liver damage, high CD95 ligand messenger RNA expression was found in hepatocytes. These findings suggest that liver destruction in hepatitis B may primarily involve killing of hepatocytes by T lymphocytes using the CD95 receptor-ligand system. In alcoholic liver damage, death of hepatocytes might occur by fratricide and paracrine or autocrine mechanisms mediated by the hepatocytes themselves.
Similar articles
-
CD40 ligation induces Apo-1/Fas expression on human B lymphocytes and facilitates apoptosis through the Apo-1/Fas pathway.J Exp Med. 1995 Nov 1;182(5):1557-65. doi: 10.1084/jem.182.5.1557. J Exp Med. 1995. PMID: 7595225 Free PMC article.
-
Involvement of CD95 (Apo-1/Fas) ligand expressed by rat Kupffer cells in hepatic immunoregulation.Gastroenterology. 1999 Mar;116(3):666-77. doi: 10.1016/s0016-5085(99)70189-7. Gastroenterology. 1999. PMID: 10029626
-
Fas system and apoptosis in viral hepatitis.J Gastroenterol Hepatol. 1997 Oct;12(9-10):S223-6. doi: 10.1111/j.1440-1746.1997.tb00504.x. J Gastroenterol Hepatol. 1997. PMID: 9407341
-
On the role and significance of Fas (Apo-1/CD95) ligand (FasL) expression in immune privileged tissues and cancer cells using multiple myeloma as a model.Leuk Lymphoma. 1998 Nov;31(5-6):477-90. doi: 10.3109/10428199809057607. Leuk Lymphoma. 1998. PMID: 9922038 Review.
-
CD95-induced apoptosis in human liver disease.Semin Liver Dis. 1998;18(2):141-51. doi: 10.1055/s-2007-1007150. Semin Liver Dis. 1998. PMID: 9606811 Review.
Cited by
-
IL-33-Pretreated Mesenchymal Stem Cells Attenuate Acute Liver Failure by Improving Homing and Polarizing M2 Macrophages.Stem Cells Int. 2024 Oct 23;2024:1273099. doi: 10.1155/2024/1273099. eCollection 2024. Stem Cells Int. 2024. PMID: 39478979 Free PMC article.
-
Combination antibody-based cancer immunotherapy.Cancer Sci. 2007 Sep;98(9):1297-302. doi: 10.1111/j.1349-7006.2007.00529.x. Epub 2007 Jun 8. Cancer Sci. 2007. PMID: 17559424 Free PMC article. Review.
-
Rous-Whipple Award Lecture. Viruses, immunity, and cancer: lessons from hepatitis B.Am J Pathol. 2000 Apr;156(4):1117-32. doi: 10.1016/s0002-9440(10)64980-2. Am J Pathol. 2000. PMID: 10751335 Free PMC article. Review. No abstract available.
-
Expression of Fas ligand in liver metastases of human colonic adenocarcinomas.Proc Natl Acad Sci U S A. 1997 Jun 10;94(12):6420-5. doi: 10.1073/pnas.94.12.6420. Proc Natl Acad Sci U S A. 1997. PMID: 9177233 Free PMC article.
-
Recent advances in the treatment of malignant melanoma with gene therapy.Mol Med. 1997 Oct;3(10):636-51. Mol Med. 1997. PMID: 9392001 Free PMC article. Review. No abstract available.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous